21/667 |
Treatment of Dermatological and Rheumatological Conditions |
21/666 |
Low and Mid Tech Communication Aid Device |
21/664 |
Medication Treatments |
21/663 |
Agency Staff |
21/660 |
Clinic Letters |
21/659 |
Impact of Covid Visiting Policies |
21/658 |
Trust Nursing Staff |
21/657 |
Maternity Beds |
21/654 |
Treatment of Ovarian Cancer |
21/652 |
Treatment of Urothelial Cancer |
21/651 |
Data Management Systems |
21/650 |
Patient Safety Incidents Resulting in Severe Harm or Death |
21/649 |
COVID-19 |
21/648 |
Haemophilia A Patients |
21/645 |
Treatment of Dermatological Conditions |
21/644 |
Endoscopy Administrative Staff |
21/643 |
Mailing |
21/642 |
Maternity Services |
21/640 |
External Courier Use |
21/638 |
Hospital Staff Assaults |